Carisma Therapeutics, Inc. (CARM)
收市後：
| 前收市價 | 1.6300 |
| 開市 | 1.6400 |
| 買盤 | 1.5800 x 400 |
| 賣出價 | 1.6100 x 200 |
| 今日波幅 | 1.5250 - 1.6640 |
| 52 週波幅 | 1.5250 - 9.7660 |
| 成交量 | |
| 平均成交量 | 168,116 |
| 市值 | 66.468M |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.5900 |
| 業績公佈日 | 2024年5月09日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 9.00 |
ZacksCarisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
CARISMA THERAP (CARM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksHere's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock Now
CARISMA THERAP (CARM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
InvestorPlace3 Top Under-$5 Stocks for Strong Gains and Positive Outlook
To clearly set expectations from the get-go, these top stocks under $5 represent extraordinary risks. As either small or even micro-capitalization enterprises, you automatically should assume volatility when entering this arena. It’s just a fact of life, nothing more: higher risks, (maybe) higher rewards. At the same time, walking the path of being a volatility luddite might not be suitable for everyone. We’re all humans. Every now and then, we get the itch to speculate. That’s why places like L
